Biote corp.

Nov 8, 2023 · Biote Corp. (BTMD) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of $0.08. This compares to loss of $0.09 per share a year ago. These figures are adjusted ... biote Corp. Up to 72,069,990 Shares of Class A Common Stock . Up to 67,856,462 Shares of Class A Common Stock . Up to 5,566,666 Warrants. This prospectus supplement supplements the prospectus dated July 19, 2022 (the “Prospectus”), which forms a part of our registration statement on Form S-1 (No. 333-265714), as amended.On May 26, 2022 (the “Closing Date”), the Business Combination with Holdings was consummated, resulting in Biote being organized in an “Up-C” structure, and HYAC as the registrant changed its name to “biote Corp. ” Biote’s headquarters are located at 1875 W. Walnut Hill Ln #100 Irving, Texas 75038.Jun 8, 2023 · As previously disclosed, on May 9, 2023, biote Corp. (the “ Company ”), commenced (i) its offer to each holder of its outstanding warrants, each whole warrant exercisable for one share of Class A Common Stock, par value $0.0001 per share (“ Common Stock ”), of the Company, at an exercise price of $11.50 per share (the “ Warrants ”), the opportunity to receive 0.23 shares of Common ...

As of November 22, 2023, biote Corp had a $371.1 million market capitalization, putting it in the 53rd percentile of companies in the Professional Information Services industry. biote Corp does not have a meaningful P/E due to negative earnings over the last 12 trailing months. biote Corp’s trailing 12-month revenue is $184.1 million …

NEW YORK, May 24, 2022 (GLOBE NEWSWIRE) — Haymaker Acquisition Corp. III (Nasdaq: HYAC) (“Haymaker” or the “Company”), a publicly traded special purpose acquisition company, today announced that its stockholders voted to approve the previously announced business combination (the “Business Combination”) with Biote, and the related ...

biote Corp. has announced the launch of a new Men's Health Division with the mission of redefining wellness for men through innovation in hormone education and optimization. Coinciding with National Men's Health Month and headed by Biote General Manager John Denne, this new division will focus on increasing awareness, education …August 24, 2022 08:30 AM Eastern Daylight Time. IRVING, Texas-- ( BUSINESS WIRE )-- biote Corp. (“Biote” or the “Company”), a high growth, differentiated medical practice-building business ...biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a high growth, differentiated medical practice-building business within the hormone optimizatioJun 10, 2022 · Innovative physician leader brings over 20 years of experience to Biote’s executive team. IRVING, Texas--(BUSINESS WIRE)--Jun. 16, 2022-- biote Corp. (“Biote” or the “Company”) (Nasdaq: BTMD), a high growth, medical practice-building business within the hormone optimization space, today announced that it has appointed Ross W. McQuivey, M.D., as its Chief Medical Officer, effective ...

biote Corp. (BTMD) delivered earnings and revenue surprises of -237.50% and 4.90%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock...

Nov 7, 2023 · biote Corp. (BTMD) delivered earnings and revenue surprises of -237.50% and 4.90%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Average Age. Experienced Board: BTMD's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board. View Ownership. Learn about biote Corp. (BTMD) stock's management team. Comprehensive performance, salary and tenure analysis for the CEO, board and leadership team.May 26, 2022 · On May 26, 2022, Haymaker completed the Business Combination with Biote and changed its name to “biote Corp.”. On May 26, 2022, the Company issued a press release announcing the consummation of the Business Combination. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The company, biote Corp Registered Shs -A-, is set to host investors and clients on a conference call on 3/29/2023 2:43:00 PM. The call comes afte... The company, biote Corp Registered Shs -A-, is set to host investors and clients on a conf...Dec 31, 2022 · Biote Corp. Consolidated Statements of Cash Flows (In Thousands) (Unaudited) Year Ended December 31, 2022 2021 Operating Activities: Net income $ 1,324 $ 32,619 Adjustments to reconcile net income to net cash (used in) provided by operating activities: Depreciation and amortization 2,199 1,400 Bad debt expense (recoveries) Biote Corp. Consolidated Balance Sheets (In Thousands) (Unaudited) September 30, December 31, 2023 2022 Assets: Current assets: Cash and cash equivalents $ 65,575 $ 79,231 Short ...Jun 8, 2022 ... Business combination with Haymaker Acquisition Corp. III complete - biote Corp.'s common stock will trade on the Nasdaq Stock Exchange under the ...

IRVING, Texas--(BUSINESS WIRE)--Nov. 10, 2022-- biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading innovator in preventive health care through the delivery of personalized hormone therapy, today announced its participation in the Jefferies London Healthcare Conference, November 15-17, 2022, in Aldwych, London.. Biote …Nov 29, 2023 · When you look at biote Corp’s price-to-sales ratio at 0.83 compared to the industry median at 4.54, this company has a lower price relative to revenue compared to its peers. This could make biote Corp’s stock more attractive for value investors. Now, let’s assess biote Corp’s EV/EBITDA ratio, also known as enterprise multiple. NEW YORK, May 17, 2022 (GLOBE NEWSWIRE) — Haymaker Acquisition Corp. III (Nasdaq: HYAC) (“Haymaker” or the “Company”), a publicly traded special purpose acquisition company, reminds its shareholders to vote in favor of the proposed business combination with BioTE Holdings, LLC (“Biote”) and the related proposals at …Exhibit 99.1 . Biote Appoints Debby Morris to Board of Directors . IRVING, TX – November 7, 2022 – biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading innovator in preventive health care through the delivery of personalized hormone therapy, today announced the appointment of Debby Morris to Biote’s Board of Directors.biote Corp. provides precision and preventive medicines. The Company offers hormone therapy and products that boosts energy and immune system. biote serves customers …

IRVING, Texas--(BUSINESS WIRE)--Nov. 10, 2022-- biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading innovator in preventive health care through the delivery of personalized hormone therapy, today announced its participation in the Jefferies London Healthcare Conference, November 15-17, 2022, in Aldwych, London.. Biote …

IRVING, Texas-- ( BUSINESS WIRE )--biote Corp., (Nasdaq: BTMD) (“Biote” or the “Company”), a high growth, differentiated medical practice-building business within the hormone optimization...NEW YORK, May 24, 2022 (GLOBE NEWSWIRE) — Haymaker Acquisition Corp. III (Nasdaq: HYAC) (“Haymaker” or the “Company”), a publicly traded special purpose acquisition company, today announced that its stockholders voted to approve the previously announced business combination (the “Business Combination”) with Biote, and the …Conference Call: Biote management will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET on Wednesday, November 8, 2023.To access the conference call by telephone, please dial (844) 481-2820 (U.S toll-free) or (412) 317-0679 (International).To access a live webcast of the call, …Biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build, and implement a program designed to optimize hormone levels. The Company's Biote Method is a comprehensive, end-to-end practice …On March 4, 2021, HYAC completed its IPO. On the Closing Date, the Business Combination with Biote was consummated, resulting in the Combined Company being organized in an “Up-C” structure, and HYAC as the registrant changed its name to “biote Corp.” Biote’s headquarters is located at 1875 W. Walnut Hill Ln #100 Irving, Texas 75038.Stock analysis for Biote Corp (BTMD:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.CBS’s hit series NCIS is a police procedural that follows a fictional group of special agents tasked with solving crimes related to the United States Department of the Navy (which includes the Marine Corps).Ms. Puncochar to Drive Execution of Biote’s Strategic Sales and Marketing Initiatives. IRVING, Texas--(BUSINESS WIRE)--May 30, 2023-- biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today announced the appointment …Terry joined Biote to drive permanent industry innovation in the hormone optimization market, addressing the 200 million individuals in the U.S. who suffer from hormone imbalance. Terry’s team-first focus has consistently resulted in growth, both in the financials of the $100 million to $2.5 billion companies she has led, and in the personal ... Biote is the nation's largest hormone optimization company and one of the only companies actively contributing to furthering the science behind hormone ...

On November 8, 2023, Biote Corp. ( BTMD) pleasantly surprised investors with their quarterly earnings report. The company reported earnings of $0.24 per share, surpassing the analyst consensus estimate of $0.07 by an impressive 242.86%. This marks a significant improvement compared to the same period last year, where the company experienced ...

EX-99.1. IRVING, TX, May 26, 2022 biote Corp., (Nasdaq: BTMD) ( Biote or the Company ), a high growth, differentiated medical practice-building business within the hormone optimization space, today announced that it has completed its business combination with Haymaker Acquisition Corp. III (Nasdaq: HYAC) ( Haymaker ), a special purpose ...

Check biote Corp’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. BTMD Stock Performance. USD USD; Previous close: 5.04: 5.04: Day range: 4.93 - 5.134.93 - 5.13Year range: 2 - 82 - 8Market cap: 395372000: 395372000: Primary exchange: NASDAQ: NASDAQ: biote Corp ...biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified ...Nov 7, 2023 · Biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build, and implement a program designed to optimize hormone levels. On March 4, 2021, HYAC completed its IPO. On the Closing Date, the Business Combination with Biote was consummated, resulting in the Combined Company being organized in an “Up-C” structure, and HYAC as the registrant changed its name to “biote Corp.” Biote’s headquarters is located at 1875 W. Walnut Hill Ln #100 Irving, Texas 75038. Revenue for the second quarter of 2023 was $49.3 million, an increase of 19.1% from $41.4 million for the second quarter of 2022. The increase was driven by procedure revenue growth of 9.8% and dietary supplement revenue growth of 52.8%. Second quarter dietary supplement revenue benefited from a successful seasonal promotion for Biote ...Ms. Puncochar to Drive Execution of Biote’s Strategic Sales and Marketing Initiatives. IRVING, Texas--(BUSINESS WIRE)--May 30, 2023-- biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today announced the appointment of Mary J. Puncochar as Chief Commercial Officer.Biote Corp. (the “Company”) is offering holders of a total of 13,504,132 aggregate Public Warrants and Private Warrants to purchase shares of the Company’s Class A common stock, par value $0.0001 per share (“Class A common stock”), outstanding as of May 9, 2023 the opportunity to exchange such warrants and receive 0.23 shares of Class ...BIGBEAR AI HOLDINGS CORP. BBAI. Technology. BIOATLA. BCAB. Health Care. BIOMEA FUSION. BMEA. Health Care. BIOTE CORP. BTMD. Health Care. BIOVIE. BIVI. Health ...biote Corp. returned to profitability in Q3 2023 and is expected to continue to be profitable in the future. The company's growth is driven by the sale of hormone replacement therapy products and ...On March 4, 2021, HYAC completed its IPO. On the Closing Date, the Business Combination with Biote was consummated, resulting in the Combined Company being organized in an “Up-C” structure, and HYAC as the registrant changed its name to “biote Corp.” Biote’s headquarters is located at 1875 W. Walnut Hill Ln #100 Irving, Texas 75038. Biote Holdings, a provider of hormone-replacement therapies, is going public through a merger with blank-check company Haymaker Acquisition Corp. III.. The combination of Irving, Texas-based Biote ...

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize …Description. Filing Group. View. Nov 14, 2023. 424B3. Form of prospectus reflecting facts events constituting substantive change from last form. Registration Statements. View HTML. 0000950170-23-063215.pdf.Nov 8, 2023 · biote Corp is down 23.75% from its previous closing price of $5.81. During the last market session, biote Corp’s stock traded between $5.60 and $5.81. Currently, there are 20.70 million shares of biote Corp stock available for purchase. Unfortunately, biote Corp’s P/E ratio is not significant enough to use for stock price evaluation. Instagram:https://instagram. stock holdaccel entertainment stockcomstock resources stock pricesocusign stock Item 1.01. Entry into a Material Definitive Agreement. Amended and Restated Investor Rights Agreement. On July 19, 2022, biote Corp. (the "Company") entered into an Amended and Restated Investor Rights Agreement, by and among the Company, Haymaker Sponsor III LLC (the "Sponsor") and the other partiers thereto (the "A&R IRA"), which …Biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build, and implement a program designed to optimize hormone levels. The Company's Biote Method is a comprehensive, end-to-end practice … best software to manage investment portfolionysearca hyg Achieved Full Year 2022 Record Revenue and Adjusted EBITDA for Full Year 2022 Expect 2023 Revenue of $190-200 million and Adjusted EBITDA of $56-60 million Significantly Increased Trading Liquidity with Recent Successful Secondary Offering IRVING, Texas --(BUSINESS WIRE)--Mar. most popular reits CBS’s hit series NCIS is a police procedural that follows a fictional group of special agents tasked with solving crimes related to the United States Department of the Navy (which includes the Marine Corps).WHO IS BIOTE? Biote is a leading innovator in precision and preventive medicine. For patients, it is a way for them to take control of their health through hormone optimization. For providers, it’s a way to learn how to identify and address the earliest indicators of aging.*